Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Accenture
Covington
US Army
McKesson
Dow
US Department of Justice
Fish and Richardson
Johnson and Johnson
Fuji
AstraZeneca

Generated: February 18, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020768

« Back to Dashboard

NDA 020768 describes ZOMIG, which is a drug marketed by Astrazeneca and IPR and is included in three NDAs. It is available from four suppliers. There are two patents protecting this drug and two Paragraph IV challenges. Additional details are available on the ZOMIG profile page.

The generic ingredient in ZOMIG is zolmitriptan. There are twenty drug master file entries for this compound. Twenty suppliers are listed for this compound. Additional details are available on the zolmitriptan profile page.
Summary for 020768
Tradename:ZOMIG
Applicant:Ipr
Ingredient:zolmitriptan
Patents:0
Therapeutic Class:Antimigraine Agents
Formulation / Manufacturing:see details
Pharmacology for NDA: 020768
Suppliers and Packaging for NDA: 020768
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ZOMIG zolmitriptan TABLET;ORAL 020768 NDA Global Pharmaceuticals, Division of Impax Laboratories Inc. 0115-0671 N 0115-0671-51
ZOMIG zolmitriptan TABLET;ORAL 020768 NDA Global Pharmaceuticals, Division of Impax Laboratories Inc. 0115-0672 N 0115-0672-50

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength2.5MG
Approval Date:Nov 25, 1997TE:ABRLD:Yes

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength5MG
Approval Date:Nov 25, 1997TE:ABRLD:Yes

Expired US Patents for NDA 020768

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Ipr ZOMIG zolmitriptan TABLET;ORAL 020768-002 Nov 25, 1997 ➤ Try a Free Trial ➤ Try a Free Trial
Ipr ZOMIG zolmitriptan TABLET;ORAL 020768-001 Nov 25, 1997 ➤ Try a Free Trial ➤ Try a Free Trial
Ipr ZOMIG zolmitriptan TABLET;ORAL 020768-001 Nov 25, 1997 ➤ Try a Free Trial ➤ Try a Free Trial
Ipr ZOMIG zolmitriptan TABLET;ORAL 020768-002 Nov 25, 1997 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Dow
Citi
Chubb
Cantor Fitzgerald
Healthtrust
Mallinckrodt
Colorcon
QuintilesIMS
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot